Brief Summary
The aim of this study is to assess feasibility, tumour response, adverse events, and quality of life of aerosolised chemotherapya cancer treatment that uses drugs to kill or slow the growth of cancer cells, while minimising damage to healthy cells in peritoneal cancer/s.
Intervention/Treatment
- Intervention: PIPAC
Inclusion Criteria
- Adult patients (> 18 years of age).
- Clinical confirmation of peritoneal carcinomatosis from gastric, pancreatic, appendiceal or colorectal cancer.
- Previous histopathological evidence of neoplastic disease is available.
- Patients must have demonstrated resistance to or lack of response to already approved and available systemic chemotherapy.
- Must have the ability to understand and sign a written informed consent form, which must be obtained prior to initiation of study procedures.